APA (7th ed.) Citation

C, A., V, B., SN, B., S, B., J, T. B., P, C., . . . CL, M. (2026). Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression. Frontiers in immunology, 17, 1730342. https://doi.org/10.3389/fimmu.2026.1730342

Chicago Style (17th ed.) Citation

C, Abrate, et al. "Targeting CD39 in Combination with IL-2/anti-IL-2 Complexes Enhances Cytotoxic Immunity and Limits Tumor Progression." Frontiers in Immunology 17 (2026): 1730342. https://doi.org/10.3389/fimmu.2026.1730342.

MLA (9th ed.) Citation

C, Abrate, et al. "Targeting CD39 in Combination with IL-2/anti-IL-2 Complexes Enhances Cytotoxic Immunity and Limits Tumor Progression." Frontiers in Immunology, vol. 17, 2026, p. 1730342, https://doi.org/10.3389/fimmu.2026.1730342.